Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Cash & Current Investments: 2009-2025

Historic Cash & Current Investments for China Pharma Holdings (CPHI) over the last 16 years, with Sep 2025 value amounting to $300,000.

  • China Pharma Holdings' Cash & Current Investments fell 58.26% to $300,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year decrease of 47.20%. This contributed to the annual value of $626,879 for FY2024, which is 55.97% down from last year.
  • According to the latest figures from Q3 2025, China Pharma Holdings' Cash & Current Investments is $300,000, which was down 52.00% from $625,032 recorded in Q2 2025.
  • China Pharma Holdings' Cash & Current Investments' 5-year high stood at $4.9 million during Q4 2021, with a 5-year trough of $300,000 in Q3 2025.
  • Its 3-year average for Cash & Current Investments is $829,461, with a median of $739,337 in 2024.
  • Its Cash & Current Investments has fluctuated over the past 5 years, first soared by 594.97% in 2022, then tumbled by 68.59% in 2023.
  • Over the past 5 years, China Pharma Holdings' Cash & Current Investments (Quarterly) stood at $4.9 million in 2021, then crashed by 58.22% to $2.0 million in 2022, then dropped by 29.86% to $1.4 million in 2023, then tumbled by 55.97% to $626,879 in 2024, then crashed by 58.26% to $300,000 in 2025.
  • Its Cash & Current Investments was $300,000 in Q3 2025, compared to $625,032 in Q2 2025 and $412,688 in Q1 2025.